Leaflet ZINBA 250UI/ 5000UI/g ointment


Indicated for: bacterial infections

Route of administration: cutaneous

Substance: zinc bacitracin + neomycin (antibacterial antibiotic + aminoglycoside antibiotic)

ATC: D06AX04 (Dermatologicals | Antibiotics for topical use | Other antibiotics for topical use)

Bacitracin zinc+neomycin is a combination of antibiotics used topically for the prevention and treatment of minor skin infections such as cuts, burns, and abrasions. Bacitracin is a polypeptide antibiotic that inhibits bacterial cell wall synthesis, while neomycin is an aminoglycoside that interferes with bacterial protein synthesis.

This combination is available as an ointment and is applied directly to the skin, usually 1-3 times daily, depending on the severity of the lesion. It is effective against a wide range of gram-positive and gram-negative bacteria.

Common side effects include local irritation, redness, and a burning sensation at the application site. In rare cases, prolonged use may lead to allergic reactions or the development of bacterial resistance. It is important for patients to avoid excessive use and follow the doctor's instructions.

Bacitracin zinc+neomycin is an effective and affordable option for managing minor skin infections, contributing to the prevention of complications and the rapid healing of lesions.

General data about ZINBA 250UI/ 5000UI/g

  • Substance: zinc bacitracin + neomycin
  • Date of last drug list: 01-10-2024
  • Commercial code: W69371002
  • Concentration: 250UI / 5000UI / g
  • Pharmaceutical form: ointment
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: ANTIBIOTICE S.A. - ROMANIA
  • Holder: ANTIBIOTICE S.A. - ROMANIA
  • Number: 14833/2023/02
  • Shelf life: 3 years-after packaging for sale; 4 months-after the first opening of the tube

Pharmaceutical forms available for zinc bacitracin + neomycin